id=44). In January 2005, the U.S. Food and Drug Administration licensed a new tetravalent meningococcal conjugate vaccine ([MCV4] Menactra) for use in people 11-55 years of age. MCV4 contains ...

MOBILE, Ala. (WALA) - The Mobile County Health Department has confirmed a case of meningococcal disease -- the first case reported in the county this year. Meningococcal disease can cause ...

The shortage of MCV4 that occurred shortly after routine administration was recommended provides an example of limited supply leading to decreased vaccination rates. [20] This type of vaccine ...

The FDA has started a review of GSK’s five-in-one meningococcal vaccine, cueing up a decision in mid-February next year, as it tries to chase down a rival candidate from Pfizer cleared last year.

Rules Relating to the Breast and Cervical Cancer Prevention and Treatment Act (BCCPTA) in Maine; 10-144 CMr Ch. 708 Proposed Rule 10-144 CMR Ch. 708 Notice 10-144 Ch. 708 The Department is proposing ...

Beginning Jan. 2014, Texas state law (SB 62) mandates that all entering students under the age of 22 provide a certificate signed by a health care provider or an official immunization record verifying ...